Dr. Xiaomei Li 李小梅
Chief Physician, Associate Professor
Department of Medical Oncology, Chinese PLA General Hospital (301 Hospital), First Medical Center, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Personalized treatment for malignant tumors and comprehensive care for advanced-stage cancer.
Dr. Li holds a doctoral degree from the PLA Medical School. In 2007, Dr. Li studied at the Cancer Centers of the University of Sydney and the University of New South Wales. Professional focus includes personalized treatment for patients with advanced cancer, symptom control, and quality of life research.
Professional roles
- Vice President, Chinese Geriatric Oncology Society
- Executive Committee Member, Chinese Society of Clinical Oncology (CSCO)
- Chair, Beijing Cancer Palliative and Rehabilitation Therapy Professional Committee
- Standing Editorial Board Member, Annals of Palliative Medicine
Name order: in Chinese the family name comes first (Li Xiaomei). Papers usually list the name as Xiaomei Li or Li X.
Selected publications
14 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Geriatr Oncol, 2025 (senior author): Translation and psychometric validation of the Chinese version of the self-administered Geriatric-8 (S-G8) questionnaire for older patients with cancer. PubMed 40706252
- Oncology, 2025 (senior author): Characteristics and Risk Factors of Immune Checkpoint Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer: A Retrospective Study. PubMed 39929164
- BMC Palliat Care, 2023 (first author): National survey on the availability of oncology palliative care services at tertiary general and cancer hospitals in China. PubMed 37770965
- Oncol Lett, 2017 (first author): Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data. PubMed 28521423
- Medicine (Baltimore), 2017 (first author): Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis. PubMed 28383415
- Medchemcomm, 2017 (first author): Discovery of potent human lactate dehydrogenase A (LDHA) inhibitors with antiproliferative activity against lung cancer cells: virtual screening and biological evaluation. PubMed 30108775
- Sci Rep, 2017 (first author): Psychological distress and cancer pain: Results from a controlled cross-sectional survey in China. PubMed 28074915
- Chin J Cancer Res, 2014 (first author): A preliminary report on adjuvant analgesic efficacy of HANS in opioid tolerant patients with cancer pain. PubMed 24826058
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion